Skip to main content
辰光医疗 logo

辰光医疗 — Investor Relations & Filings

Ticker · 920300 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2024-05-07 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920300

About 辰光医疗

http://www.shanghaicg.net/

Shanghai Chenguang Medical Technologies Co., Ltd. specializes in the research, development, and manufacturing of core components for Magnetic Resonance Imaging (MRI) systems. The product portfolio includes high-performance radiofrequency (RF) coils, superconducting magnets, and gradient coils designed for clinical, preclinical, and veterinary applications. The company focuses on high-field and ultra-high-field MRI technology, providing customized hardware solutions and integrated components to global imaging equipment manufacturers. Its technical capabilities encompass electromagnetic simulation, structural design, and precision manufacturing of specialized imaging hardware.

Recent filings

Filing Released Lang Actions
关于子公司完成工商登记及公司章程备案并取得换发营业执照的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shanghai Chenguang Medical Technology Co., Ltd. regarding the completion of business registration and filing of company articles for its subsidiaries, including obtaining new business licenses. It details changes in subsidiaries' business scope, registered capital, and addresses, and references prior board meeting resolutions. The document is relatively short (1825 characters) and focuses on corporate administrative updates rather than financial results or detailed reports. It does not contain financial statements or detailed financial data. This type of announcement fits best under Regulatory Filings (RNS), as it is a general regulatory announcement about corporate changes and filings without constituting a full report or financial disclosure.
2024-05-07 Chinese
2024年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2024 年第一季度报告" which translates to "2024 First Quarter Report." It contains detailed financial data including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the period January to March 2024. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis. It is not an announcement or a brief summary but a full financial report for a period shorter than a fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2024
2024-04-25 Chinese
第五届董事会第十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from Shanghai Chunguang Medical Technology Co., Ltd. It details the convening and attendance of the 11th meeting of the 5th board of directors, including the approval of the 2024 first quarter report. The document references the actual quarterly report being disclosed on the Beijing Stock Exchange information platform, indicating this document is not the report itself but an announcement of the board's approval of that report. The document length is short (1040 characters), and it primarily serves as a formal announcement of the board meeting decisions rather than containing substantive financial data or the full quarterly report. Therefore, it fits best under the category of Board/Management Information (MANG), as it announces board resolutions and meeting outcomes related to management decisions.
2024-04-25 Chinese
第五届监事会第六次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a meeting resolution announcement from the supervisory board of Shanghai Chunguang Medical Technology Co., Ltd. It reports the approval of the company's 2024 first quarter report during the supervisory board meeting. The document itself does not contain the actual financial data or the full quarterly report but references that the full 2024 first quarter report is disclosed on the Beijing Stock Exchange information platform (announcement number 2024-055). The document length is short (1009 characters) and serves as a formal announcement of the meeting resolution approving the quarterly report rather than the report itself. According to the 'Menu vs Meal' rule, this is an announcement related to a report, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a regulatory announcement about the meeting and approval of the quarterly report, not the quarterly report itself.
2024-04-25 Chinese
利润分配管理制度
Regulatory Filings Classification · 95% confidence The document is titled '利润分配管理制度' which translates to 'Profit Distribution Management System'. It details the company's policies and procedures regarding profit distribution, including dividend policies, decision-making processes, and supervisory mechanisms. The document is a formal announcement of the company's internal policy on profit distribution, approved by the board and to be submitted to the shareholders' meeting for approval. It does not contain financial statements, earnings data, or results, nor is it a report of voting results or a proxy solicitation. It is a regulatory announcement about the company's profit distribution policy framework. Given the content and length (4118 characters), it is not a full financial report or earnings release but rather a regulatory filing announcing a corporate governance policy update related to dividends and profit distribution. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2024-04-22 Chinese
关于上海辰光医疗科技股份有限公司非经营性资金占用及其他关联资金往来情况的专项审核说明
Regulatory Filings
2024-04-22 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.